Amneal Pharmaceuticals, Inc. (AMRX) Form 8-K Material Events
Amneal Pharmaceuticals, Inc. (AMRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AMRX
CIK: 1723128
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerAnthony Sgammato
Audit LocationIselin, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-21 | 2026-09-17 | FORM 4 | 0001628280-26-062915 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-11 | FORM 4 | 0001628280-26-061836 | View SEC Doc Filr Page |
| S-3ASR | 2026-09-03 | — | S-3ASR | 0001140361-26-035617 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | FORM 4 | 0001628280-26-060179 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001628280-26-058918 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-13 | FORM 4 | 0001628280-26-057147 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-12 | FORM 4 | 0001628280-26-056757 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001628280-26-056754 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | FORM 4 | 0001628280-26-056752 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001628280-26-056733 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0000898432-26-000655 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-12 | — | SCHEDULE 13D/A Filing | 0000898432-26-000654 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-12 | — | SCHEDULE 13D/A Filing | 0000898432-26-000653 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-12 | — | SCHEDULE 13D/A Filing | 0000898432-26-000652 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001628280-26-056297 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001628280-26-056288 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001628280-26-056285 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001628280-26-056220 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001628280-26-056196 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001949846-26-000494 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001140361-26-032014 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001723128-26-000031 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K | 0001628280-26-051900 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-31 | 8-K | 0001140361-26-030491 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-30 | — | DEFA14A | 0001140361-26-030141 | View SEC Doc Filr Page |